PET/CT with floe technology is the world’s first PET/CT system to eliminate the demand for stop-and-go imaging since the scanning is based on a single continuous motion of the patient table. Not only less time consumption but PET/CT Flow also provides patients a smooth and convenient scan.
Presently, diagnosis with PET/CT scan utilizes F-18 FDG radiopharmaceutical in more than 90% of cases. Other radiopharmaceuticals for instance F-18 FD0PA is used in certain types of cancers and brain disorders such as Parkinson’s and other movement disorders, while the C-11 PiB (Pittsburgh Compound) is applicable to Alzheimer’s disease.